KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Pacific Biosciences Of California (PACB) Gross Profit (2016 - 2026)

Pacific Biosciences Of California has reported Gross Profit over the past 16 years, most recently at $16.6 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 64.7% year-over-year to $16.6 million; the TTM value through Dec 2025 reached $45.8 million, up 22.79%, while the annual FY2025 figure was $45.8 million, 22.79% up from the prior year.
  • Gross Profit for Q4 2025 was $16.6 million at Pacific Biosciences Of California, up from $15.9 million in the prior quarter.
  • Over five years, Gross Profit peaked at $17.9 million in Q3 2023 and troughed at -$1.4 million in Q1 2025.
  • A 5-year average of $12.0 million and a median of $13.5 million in 2022 define the central range for Gross Profit.
  • On a YoY basis, Gross Profit climbed as much as 147.29% in 2025 and fell as far as 112.15% in 2025.
  • Year by year, Gross Profit stood at $16.8 million in 2021, then crashed by 69.34% to $5.1 million in 2022, then soared by 86.21% to $9.6 million in 2023, then rose by 5.09% to $10.1 million in 2024, then skyrocketed by 64.7% to $16.6 million in 2025.
  • Business Quant data shows Gross Profit for PACB at $16.6 million in Q4 2025, $15.9 million in Q3 2025, and $14.7 million in Q2 2025.